Consumption of PPI Drugs in Primary Health Care in Albania During 2010-2020


  • Laerta Kakariqi "Department of Biomedical and Experimental, Section of Pharmacology, Faculty of Medicine, University of Medicine in Tirana, Tirana, Albania"


Drug utilization, DDD/1000 inhabitants/day, PPI drugs


The aim of the study was to estimate the out-of hospital Proton-pump inhibitors use in Albania (national level) during 2010-2020. All data were collected from Health Insurance Institute (HII) and analyzed reflecting the ambulatory and outpatient use for the period 2010-2020. The data about the consumption of drugs were expressed as a number of Defined Daily Dose (DDDs) /1000 inhabitants/day. For all the period under study 2010-2020, there were collected and analyzed data of import and domestic production of drugs, which represent the real consumption of drugs in the country. These data were subsequently included in a comparative analysis with the utilization data according to the Health Insurance Institute. Furthermore, it becomes visible the poor coverage by the scheme of the necessary alternative cures of the ulcerous disease. The reimbursement scheme offers only omeprazole. However, the consumption of omeprazole under the scheme is in much lower levels compared to the real data of omeprazole consumption coming from import figures, which shows its excessive utilization without medical prescription.




How to Cite

Kakariqi, L. . (2022). Consumption of PPI Drugs in Primary Health Care in Albania During 2010-2020. European Journal of Medicine and Natural Sciences, 6(1), 32–39. Retrieved from